# PLDT Inc.: financial statements, quarterly

PHI · NYSE · CIK 78150 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/phi.md) · [Financials](/companies/phi/financials.md) · [Filings](/companies/phi/filings.md) · [Insiders](/companies/phi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/phi/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2014-12-31) | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [26.7](/filings/0001564590-18-007647.md) | [46.5](/filings/0001564590-19-011621.md) | [38.7](/filings/0001564590-20-018086.md) | [32.9](/filings/0001564590-21-020184.md) | [51.7](/filings/0001564590-22-013696.md) | [24.4](/filings/0000950170-23-009911.md) | [40.2](/filings/0000950170-24-036733.md) | [23.9](/filings/0000950170-25-038448.md) | [25.2](/filings/0000950170-25-038448.md) | [16.2](/filings/0000950170-25-038448.md) | [10.0](/filings/0000950170-25-038448.md) |
| Current assets | $bn | not reported | not reported | [86.0](/filings/0001564590-18-007647.md) | [89.7](/filings/0001564590-19-011621.md) | [99.6](/filings/0001564590-20-018086.md) | [75.6](/filings/0001564590-21-020184.md) | [87.4](/filings/0001564590-22-013696.md) | [73.9](/filings/0000950170-23-009911.md) | [81.3](/filings/0000950170-24-036733.md) | [70.1](/filings/0000950170-25-038448.md) | [63.8](/filings/0000950170-25-038448.md) |
| Total assets | $bn | not reported | [455](/filings/0001564590-18-007647.md) | [475](/filings/0001564590-19-011621.md) | [459](/filings/0001564590-20-018086.md) | [483](/filings/0001564590-21-020184.md) | [525](/filings/0001564590-22-013696.md) | [576](/filings/0000950170-23-009911.md) | [626](/filings/0000950170-24-036733.md) | [624](/filings/0000950170-24-036733.md) | [610](/filings/0000950170-25-038448.md) | [623](/filings/0000950170-25-038448.md) |
| Current liabilities | $bn | not reported | not reported | [182](/filings/0001564590-18-007647.md) | [168](/filings/0001564590-19-011621.md) | [193](/filings/0001564590-20-018086.md) | [204](/filings/0001564590-21-020184.md) | [214](/filings/0001564590-22-013696.md) | [224](/filings/0000950170-23-009911.md) | [247](/filings/0000950170-24-036733.md) | [197](/filings/0000950170-25-038448.md) | [188](/filings/0000950170-25-038448.md) |
| Total liabilities | $bn | not reported | [341](/filings/0001564590-18-007647.md) | [367](/filings/0001564590-19-011621.md) | [348](/filings/0001564590-20-018086.md) | [366](/filings/0001564590-21-020184.md) | [409](/filings/0001564590-22-013696.md) | [456](/filings/0000950170-23-009911.md) | [499](/filings/0000950170-24-036733.md) | [510](/filings/0000950170-24-036733.md) | [499](/filings/0000950170-25-038448.md) | [507](/filings/0000950170-25-038448.md) |
| Shareholders' equity | $bn | [135](/filings/0001564590-18-007647.md) | [114](/filings/0001564590-19-011621.md) | [108](/filings/0001564590-18-007647.md) | [107](/filings/0001564590-19-011621.md) | [112](/filings/0001564590-20-018086.md) | [112](/filings/0001564590-21-020184.md) | [115](/filings/0001564590-22-013696.md) | [123](/filings/0000950170-23-009911.md) | [109](/filings/0000950170-24-036733.md) | [105](/filings/0000950170-25-038448.md) | [115](/filings/0000950170-25-038448.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 216,055,775 at 2025-12-31, from the cover of the [20-F filed 2026-04-27](/filings/0001193125-26-182147.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.